体外受精中控制性卵巢刺激的监测。
Monitoring of controlled ovarian stimulation in IVF.
机构信息
IVF Unit, Elisha Hospital, Haifa, Israel.
Department of Reproductive Medicine, Instituto Bernabeu, Alicante, Spain.
出版信息
J Assist Reprod Genet. 2024 Jul;41(7):1715-1717. doi: 10.1007/s10815-024-03182-x. Epub 2024 Jul 4.
Abstract
Since the inception of in vitro fertilization (IVF), monitoring of controlled ovarian stimulation (COS) has traditionally involved numerous appointments for ultrasound and laboratory testing to guide medication use and dosing, determine trigger timing, and allow for measures to reduce the risk of ovarian hyperstimulation syndrome (OHSS). Recent advances in the field of assisted reproductive technology (ART) have called into question the timing and frequency of COS monitoring appointments, as discussed in this commentary.
摘要
自从体外受精（IVF）诞生以来，控制性卵巢刺激（COS）的监测传统上需要进行多次超声和实验室检查，以指导药物使用和剂量、确定触发时机，并采取措施降低卵巢过度刺激综合征（OHSS）的风险。本文述评讨论了辅助生殖技术（ART）领域的最新进展对 COS 监测预约时间和频率提出的质疑。
相似文献
1
Monitoring of controlled ovarian stimulation in IVF.
J Assist Reprod Genet. 2024 Jul;41(7):1715-1717. doi: 10.1007/s10815-024-03182-x. Epub 2024 Jul 4.
2
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Cochrane Database Syst Rev. 2008 Apr 16(2):CD005289. doi: 10.1002/14651858.CD005289.pub2.
3
Ovarian stimulation in ART - Unwinding pressing issues.
Minerva Ginecol. 2015 Apr;67(2):127-47. Epub 2015 Feb 10.
4
In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.
Hum Reprod. 2022 Jan 28;37(2):242-253. doi: 10.1093/humrep/deab243.
5
GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports.
Clin Exp Obstet Gynecol. 2017;44(2):279-282.
6
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4.
7
[IVF in a modified natural cycle].
Ned Tijdschr Geneeskd. 2010;154(45):A2519.
8
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
Hum Reprod. 2017 Sep 1;32(9):1915-1924. doi: 10.1093/humrep/dex253.
9
Why more is less and less is more when it comes to ovarian stimulation.
J Assist Reprod Genet. 2015 Dec;32(12):1713-9. doi: 10.1007/s10815-015-0599-7. Epub 2015 Oct 19.
10
Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.
J Clin Endocrinol Metab. 2015 Sep;100(9):3322-31. doi: 10.1210/jc.2015-2332. Epub 2015 Jul 20.
引用本文的文献
1
High concentration of estrogen resulted by COH may affect the secretion of pro-angiogenic factors in uNK cells by downregulating the expression of IL-11 in decidual stromal cells.
J Assist Reprod Genet. 2024 Nov;41(11):3189-3200. doi: 10.1007/s10815-024-03241-3. Epub 2024 Sep 14.
本文引用的文献
1
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Cochrane Database Syst Rev. 2024 Jan 4;1(1):CD012693. doi: 10.1002/14651858.CD012693.pub3.
2
Random-start ovarian stimulation in an oocyte donation programme: a large, single-centre, experience.
Reprod Biomed Online. 2024 Jan;48(1):103572. doi: 10.1016/j.rbmo.2023.103572. Epub 2023 Oct 4.
3
Free your patients and yourself from day 2-3: start ovarian stimulation any time in freeze-all cycles.
Reprod Biomed Online. 2023 Oct;47(4):103305. doi: 10.1016/j.rbmo.2023.103305. Epub 2023 Jul 23.
4
Changing stimulation protocol on repeat conventional ovarian stimulation cycles does not lead to improved laboratory outcomes.
Fertil Steril. 2021 Sep;116(3):757-765. doi: 10.1016/j.fertnstert.2021.04.030. Epub 2021 May 24.
5
Streamlining follicular monitoring during controlled ovarian stimulation: a data-driven approach to efficient IVF care in the new era of social distancing.
Hum Reprod. 2021 Jan 1;36(1):99-106. doi: 10.1093/humrep/deaa251.
6
The number of oocytes retrieved during IVF: a balance between efficacy and safety.
Hum Reprod. 2018 Jan 1;33(1):58-64. doi: 10.1093/humrep/dex334.
7
Variation in antral follicle counts at different times in the menstrual cycle: does it matter?
Reprod Biomed Online. 2016 Aug;33(2):174-9. doi: 10.1016/j.rbmo.2016.04.012. Epub 2016 May 5.
8
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Hum Reprod. 2016 Feb;31(2):370-6. doi: 10.1093/humrep/dev316. Epub 2016 Jan 2.
9
Reducing the Risk of OHSS by GnRH Agonist Triggering.
J Clin Endocrinol Metab. 2015 Dec;100(12):4396-8. doi: 10.1210/jc.2015-3676. Epub 2015 Oct 29.
10
Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol.
Fertil Steril. 2015 Oct;104(4):884-890.e2. doi: 10.1016/j.fertnstert.2015.06.027. Epub 2015 Jul 15.
Zotero 插件